Gabriel C. Léger

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia

Marsel Mesulam, Alissa Wicklund, Nancy Johnson et al. · Annals of Neurology · 2008 · 507 citations · Full text

Dopa decarboxylase activity of the living human brain.

Albert Gjedde, Jakob Reith, Suzan Dyve et al. · Proceedings of the National Academy of Sciences · 1991 · 170 citations · Full text

Positron Emission Tomography, Molecular Neuroscience, Neurophysiology +14

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer et al. · The Lancet Neurology · 2021 · 108 citations

Neurodegenerative Diseases, Neuropsychology, Alzheimer's Disease +11

6-[¹⁸F]fluoro-l-DOPA Metabolism in Living Human Brain: A Comparison of Six Analytical Methods

Hiroaki Hoshi, Hiroto Kuwabara, Gabriel C. Léger et al. · Journal of Cerebral Blood Flow & Metabolism · 1993 · 107 citations · Full text

Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[¹⁸F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to Normal Subjects

Hiroto Kuwabara, Paul Cumming, Jakob Reith et al. · Journal of Cerebral Blood Flow & Metabolism · 1993 · 104 citations · Full text

Neurotransmitter, Dopa Decarboxylase, Social Sciences +17